Pharmaxis Shares Outstanding 2006-2018 | PXSLY

Pharmaxis shares outstanding from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Pharmaxis Annual Shares Outstanding
(Millions of Shares)
2018 21
2017 21
2016 21
2015 21
2014 21
2013 21
2012 18
2011 15
2010 15
2009 13
2008 13
2007 12
2006 11
2005
Pharmaxis Quarterly Shares Outstanding
(Millions of Shares)
Q4 2018
Q2 2017
Q4 2017
Q4 2016
Q2 2015
Q4 2015
Q2 2014
Q1 2014 20
Q4 2014 21
Q2 2013 21
Q1 2013 20
Q4 2013 21
Q3 2013 21
Q2 2012 20
Q1 2012 20
Q4 2012 20
Q3 2012 21
Q2 2011 17
Q1 2011 16
Q4 2011
Q3 2011 15
Q2 2010 15
Q1 2010 15
Q4 2010 16
Q3 2010 15
Q2 2009 13
Q1 2009 14
Q4 2009 14
Q3 2009 13
Q2 2008 14
Q1 2008 11
Q4 2008 12
Q3 2008 12
Q2 2007 189
Q1 2007 12
Q4 2007 174
Q3 2007 177
Q2 2006 179
Q1 2006 12
Q4 2006 12
Q3 2006 12
Q2 2005 159
Q1 2005 9,013
Q4 2005
Q3 2005
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.041B $0.039B
Pharmaxis develops innovative pharmaceutical products to treat human respiratory and autoimmune diseases. Its development pipeline of products include AridolTM for asthma, BronchitolTM for cystic fibrosis and chronic obstructive pulmonary disease and PXS64 for multiple sclerosis.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $66.758B 39.93
Takeda Pharmaceutical (TAK) Japan $62.374B 9.86
Astellas Pharma (ALPMY) Japan $32.724B 16.34
Eisai (ESALY) Japan $21.612B 41.66
Merck (MKGAF) Germany $16.401B 22.38
Grifols, S.A (GRFS) Spain $16.254B 21.30
Neurocrine Biosciences (NBIX) United States $9.639B 455.09
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Catalent (CTLT) United States $8.907B 36.24
Jazz Pharmaceuticals (JAZZ) Ireland $8.545B 10.91
Ionis Pharmaceuticals (IONS) United States $8.458B 17.13
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
IPSEN SA ADR (IPSEY) France $7.617B 0.00
STADA ARZNEIMI (STDAF) Germany $6.004B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.990B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
Hypermarcas (HYPMY) Brazil $5.646B 17.17
Arrowhead Pharmaceuticals (ARWR) United States $5.400B 81.77
Evotec AG (EVTCY) Germany $4.191B 67.73
United Therapeutics (UTHR) United States $4.087B 0.00
Sage Therapeutics (SAGE) United States $3.959B 0.00
Nektar Therapeutics (NKTR) United States $3.955B 0.00
FibroGen (FGEN) United States $3.870B 113.72
PTC Therapeutics (PTCT) United States $3.316B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.273B 12.05
ChemoCentryx (CCXI) United States $2.534B 0.00
Zogenix (ZGNX) United States $2.433B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.150B 0.00
Xencor (XNCR) United States $2.130B 64.74
Tilray (TLRY) Canada $2.108B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.976B 63.00
Heron Therapeutics (HRTX) United States $1.941B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.829B 54.10
USANA Health Sciences (USNA) United States $1.760B 18.78
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.525B 10.41
CLINIGEN GP (CLIGF) United Kingdom $1.506B 0.00
Corcept Therapeutics (CORT) United States $1.474B 17.92
Theravance Biopharma (TBPH) Cayman Islands $1.432B 0.00
Endo (ENDP) Ireland $1.370B 2.52
Enanta Pharmaceuticals (ENTA) United States $1.148B 26.10
Portola Pharmaceuticals (PTLA) United States $1.118B 0.00
Karyopharm Therapeutics (KPTI) United States $1.070B 0.00
Aerie Pharmaceuticals (AERI) United States $1.053B 0.00
Dermira (DERM) United States $1.044B 0.00
Akebia Therapeutics (AKBA) United States $0.955B 0.00
Radius Health (RDUS) United States $0.907B 0.00
Collegium Pharmaceutical (COLL) United States $0.785B 0.00
ImmunoGen (IMGN) United States $0.683B 0.00
Flexion Therapeutics (FLXN) United States $0.668B 0.00
TherapeuticsMD (TXMD) United States $0.626B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.576B 0.00
Molecular Templates (MTEM) United States $0.507B 0.00
Organogenesis Holdings (ORGO) United States $0.501B 0.00
DURECT (DRRX) United States $0.483B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.483B 0.00
Translate Bio (TBIO) United States $0.483B 0.00
Ardelyx (ARDX) United States $0.470B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.453B 0.00
Innate Pharma SA (IPHYF) France $0.438B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.429B 52.00
Siga Technologies (SIGA) United States $0.422B 9.63
BioSpecifics Technologies Corp (BSTC) United States $0.419B 18.08
Aptorum Group (APM) Hong Kong, SAR China $0.418B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.412B 0.00
Calithera Biosciences (CALA) United States $0.398B 0.00
Lannett Co Inc (LCI) United States $0.393B 4.58
Spectrum Pharmaceuticals (SPPI) United States $0.366B 0.00
Recro Pharma (REPH) United States $0.366B 0.00
Harpoon Therapeutics (HARP) United States $0.357B 0.00
OptiNose (OPTN) United States $0.356B 0.00
Indivior (INVVY) United States $0.335B 1.21
KalVista Pharmaceuticals (KALV) United States $0.331B 0.00
Rafael Holdings (RFL) United States $0.325B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.289B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.286B 0.00
MEI Pharma (MEIP) United States $0.256B 0.00
Concert Pharmaceuticals (CNCE) United States $0.248B 0.00
Concordia (CXRXF) Canada $0.248B 0.00
Jounce Therapeutics (JNCE) United States $0.241B 3.22
Ocular Therapeutix (OCUL) United States $0.223B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.210B 0.00
IMV INC (IMV) Canada $0.203B 0.00
Nature's Sunshine Products (NATR) United States $0.188B 32.43
Taiwan Liposome (TLC) Taiwan $0.170B 0.00
Xeris Pharmaceuticals (XERS) United States $0.167B 0.00
CannTrust Holdings (CTST) Canada $0.167B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.151B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.146B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.135B 0.00
Redhill Biopharma (RDHL) Israel $0.134B 0.00
CV Sciences (CVSI) United States $0.125B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.114B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.114B 0.00
Otonomy (OTIC) United States $0.110B 0.00
PolarityTE (PTE) United States $0.108B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Aquestive Therapeutics (AQST) United States $0.103B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.100B 0.00
Champions Oncology (CSBR) United States $0.098B 0.00
MediWound (MDWD) Israel $0.082B 0.00
CTI BioPharma (CTIC) United States $0.080B 0.00
Neos Therapeutics (NEOS) United States $0.080B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.077B 23.18
Aclaris Therapeutics (ACRS) United States $0.076B 0.00
Infinity Pharmaceuticals (INFI) United States $0.067B 0.00
Natural Alternatives (NAII) United States $0.066B 16.52
Entasis Therapeutics Holdings (ETTX) United States $0.064B 0.00
Nivalis Therapeutics (ALPN) United States $0.063B 0.00
SCYNEXIS (SCYX) United States $0.062B 0.00
RENEURON GP (RNUGF) United Kingdom $0.061B 0.00
Onconova Therapeutics (ONTX) United States $0.057B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.050B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.048B 0.00
Iterum Therapeutics (ITRM) Ireland $0.046B 0.00
Jaguar Animal Health (JAGX) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.043B 0.00
ElectroCore (ECOR) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Biomerica (BMRA) United States $0.029B 0.00
PharmAthene (ALT) United States $0.028B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.028B 0.00
Regulus Therapeutics (RGLS) United States $0.025B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
Bio-Path Holdings (BPTH) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Cardiome Pharma (CORV) Canada $0.019B 0.00
VAXART, INC (VXRT) United States $0.018B 0.00
Shineco (TYHT) China $0.018B 0.00
Novan (NOVN) United States $0.017B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Lipocine (LPCN) United States $0.013B 0.00
Flex Pharma (SLRX) United States $0.013B 0.00
Vical (BBI) United States $0.013B 0.00
Heat Biologics (HTBX) United States $0.012B 0.00
HANCOCK JAFFE (HJLI) United States $0.011B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.003B 0.00